UTSA
myUTSA UTSA Today Visit Directory Search
UTSA UTSA
  • About
  • Admissions
  • Academics
  • Research
  • Campus Life
  • Giving
  • Athletics
  • Alumni
  • Locations
Sombrilla - The UTSA Magazine
  • Table of Contents(current)
  • Web Exclusives
  • Past Issues
FEEDBACK
A Second Chance?
Cancer Research
A Second Chance?
A Second Chance?
Great Minds
How one medication could help reverse the effects of cancer-caused sperm loss

SHARE THIS

STORY HIGHLIGHTS

• Infertility can be a common side effect for men receiving treatment.
• Existing drug shows promise for reversing cancer-related infertility in a laboratory setting.
• Researcher hopes human testing to follow.


By Joanna Carver |
ORIGINALLY POSTED 04/01/2017 |
FROM THE SPRING 2017 ISSUE

Losing fertility is a frequent problem among many men cancer patients, particularly since treatments for the disease often halt sperm production. But a new study led by Brian Hermann, assistant professor of biology at UTSA, has shown promising evidence that a medication previously used to prevent infections in cancer patients can also keep them from becoming infertile.

Hermann and his research team have been pursuing a number of cutting-edge research initiatives to restore fertility in men who have lost their ability to have children as a result of cancer treatments they received as children. While working on methods to restart sperm production, the researchers discovered a link between a drug for recovering cancer patients and the absence of normal damage to reproductive ability.

The drug is called granulocyte colony-stimulating factor, or G-CSF. It stimulates human bone marrow to produce neutrophils, which are white blood cells that are needed to fight infections. They’re commonly lost after chemotherapy and radiation treatments.

“We were using G-CSF to prevent infections in our research experiments,” Hermann says. “It turned out that the drug also had the unexpected impact of guarding against male infertility.”

Because cancer treatments like radiation and chemotherapy often kill sperm stem cells, male reproduction becomes essentially impossible. In Hermann’s laboratory, G-CSF, by promoting cell growth, unexpectedly began creating new sperm stem cells to replace the dead ones. A study authored by Hermann and his students has been published in the journal Reproductive Biology and Endocrinology.

Hermann’s laboratory efforts focus almost exclusively on regenerating dead testicular tissue through the use of stem cells, making the project an exciting but unexpected detour that he hopes to continue, if possible.

The next step would be observing whether the drug, which is already in wide use by cancer patients, has any correlation with restored fertility among humans. Until then, Hermann is focusing on better understanding the stem cells that make reproduction possible so that he can find more effective solutions to treating male infertility.

“Male infertility is an intuitive disease, and we need creative solutions,” he says.

“But we need to understand how things work before we can fix them.”

Current Issue: Spring 2017 | Table of Contents

TOP STORIES

  • To Catch a Predator
  • A Second Chance?
  • Great Minds
  • Fact or Fake?
  • History Irreplaceable

DEPARTMENTS

  • Faces of Art
  • Monkey Business
  • Good Nature
  • Fore! Score
  • Economy Boosters
  • Bird's-eye View
  • Nurture for a Lifetime
  • A Bite Out of Lyme
  • Campus Evolution

'RUNNERS & SHAKERS

  • The Best-Laid Plans
  • Embracing the Basics
  • The Future of Computing
  • A Passionate Mission
  • Class Notes
  • In Memoriam
Back to Top

UTSA


One UTSA Circle San Antonio, TX 78249 |
Information 210-458-4011
Campus Alerts
Jobs
Required Links
Policies
UT System
Report Fraud
ADA Resources
Sexual Harassment and Sexual Misconduct Policy
Title IX Reporting
Counseling/Mental Health
Clery Information
Web Accessibility
Roadrunner Remembrance
CARES Act Reports & Disclosure
Free Speech and Civil Discourse
© 2022 The University of Texas at San Antonio
Produced by University Marketing